The KD Pharma Group, a CDMO specializing in pharmaceutical and nutritional lipids, has successfully completed its acquisition of dsm-firmenich’s Marine Lipids business.   The acquisition includes dsm-firmenich’s Marine Lipids omega-3 fish oil business for the food and beverage, dietary supplement and pharmaceutical markets, as well as the MEG-3 brand and production facilities in Piura, Peru and Mulgrave, Canada. In return, dsm-firmenich has received a minority stake in the enlarged...